Healthcare providers have long navigated the complex world of Medicare audits, working diligently to meet billing standards, document patient care thoroughly, and respond to regulatory oversight. What once existed as a strictly administrative process is now evolving into something far more serious—and punitive. Increasingly, providers are finding themselves at the intersection of standard Medicare audits
Fedtrade® Podcast – Bill Noonan, Choose New Jersey – SelectUSA Spotlight
The Fedtrade® podcast recently interviewed Bill Noonan, Chief Business Development Officer of Choose New Jersey, as part of our SelectUSA Investment Summit Spotlight series. Choose New Jersey is the state’s leading non-profit business attraction organization, inspiring businesses, entrepreneurs, and innovators to make New Jersey their home. They provide a range of free, confidential resources and
Procedure: Federal Court & Generative AI.
The following statement is to be attributed to Chief Justice of the Federal Court of Australia, Debra Mortimer: 28 March 2025 (Link to Federal Court website).
The year 2025 is likely to see a number of developments and issues about the use of Artificial Intelligence, especially Generative Artificial Intelligence, by courts and in court
Fedtrade® Podcast – Tony Davis, Australian Trade and Investment Commission on Australia/U.S. Trade
The Fedtrade® podcast recently interviewed Tony Davis, Head of North and Latin America at the Australian Trade and Investment Commission (Austrade). Austrade helps grow Australia’s prosperity by delivering quality trade and investment services to businesses, accelerates growth in Australia’s tourism sector. and promotes Australia’s education to the world.
Learn more about Austrade on their website or
Virtual and Digital Health Digest – March 2025
Welcome to the latest installment of Arnold & Porter’s Virtual and Digital Health Digest. This digest covers key virtual and digital health regulatory and public policy developments during February and early March 2025 from the United States, United Kingdom, and European Union.
Artificial intelligence (AI) has been the focus this month, with certain aspects of
Key Considerations Before Negotiating Healthcare AI Vendor Contracts
The integration of artificial intelligence (AI) tools in healthcare is revolutionizing the industry, bringing efficiencies to the practice of medicine and benefits to patients. However, the negotiation of third-party AI tools requires a nuanced understanding of the tool’s application, implementation, risk and the contractual pressure points. Before entering the negotiation room, consider the following key
Navigating Life Sciences Transactions: Lessons from the Field
This post is the fifth in our five-part series, Navigating Life Sciences Transactions, where our team of attorneys provides essential strategies and insights for successful life sciences transactions.
Throughout this series, we’ve explored the key elements of successful life sciences transactions—from structuring collaborations and securing funding to protecting intellectual property and navigating regulatory complexities.
Raising Capital in a Highly Regulated Market
This post is the second in our five-part series, Navigating Life Sciences Transactions, where our team of attorneys provides essential strategies and insights for successful life sciences transactions.
What Investors Look for in Early and Late-Stage Funding Rounds and How Regulatory Compliance Impacts Valuation
For early-stage life sciences and health tech companies, raising capital
The Role of Generative Artificial Intelligence in Patent Litigation: A New Frontier for Inventorship, Infringement and Validity
As generative artificial intelligence (AI) continues to transform industries, its impact on patent law is raising critical legal questions. From the recognition of AI as an inventor and potential infringement risks posed by the AI-generated outputs to the use of AI in patent validity challenges, the legal landscape is rapidly evolving. This article explores how generative AI
Structuring the Right Deals for Growth in Life Sciences
This post is the first in our five-part series, Navigating Life Sciences Transactions, where our team of attorneys provides essential strategies and insights for successful life sciences transactions.
AI, Medical Devices, Digital Health, and the Future of Healthcare Transactions
Innovation in life sciences isn’t just about scientific breakthroughs—it’s about making the right business decisions.